DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global E-Clinical Solution Market Size, Share, Development, Growth and Demand Forecast to 2020" report to their offering.
The global e-clinical solution market accounted for $2.9 billion value in 2014, and it is expected to grow with a CAGR of 13.7% during 2015-2020.
The global market of e-clinical solution is up surging with a significant rate, due to increasing number of clinical trials and increasing spends on clinical research and development in the pharmaceutical and biotechnology industry. In addition, the growing clinical trial outsourcing and increasing need for improved data standardization are also driving the growth of the global e-clinical solution market. The increasing clinical research in the emerging market and increasing adoption of cloud technology for the development of e-clinical suits pose opportunities for the market.
The restraints impacting the growth of the global market include high cost of implementation and less skilled manpower, long approval time for clinical trials, and lack of high speed broadband facilities and IT professionals in remote areas. The increasing number of partnerships and collaborations, increasing number of product launches and increasing number of mergers and acquisitions are the latest trends observed in the global market.
- Omnicomm Systems Inc.
- Parexel International Corporation
- Medidata Solutions Inc.
- Merge Healthcare Incorporated (Ibm Watson Health)
- Oracle Corporation
- Datatrak International Inc.
Crf Health Inc.
Key Topics Covered:
1.Research Scope And Methodology
4.Clinical Trial Regulatory Analysis
5.Global E-Clinical Solution Market Size And Forecast (2011-2020)
6.Global E-Clinical Solution Market, By Delivery Mode
7.Global E-Clinical Solution Market, By Type
8.Global E-Clinical Solution Market By Product
9.Global E-Clinical Solution Market, By End-User
10.Global E-Clinical Solution Market, By Geography
11.Competitive Positioning Analysis
12.Company Profiles And Strategic Developments
For more information about this report visit http://www.researchandmarkets.com/research/wbwdz3/global_eclinical